John Gillespie

President and CEO @ AmberGen arrow icon

About John Gillespie

John Gillespie is the President and CEO of a company, known for his extensive background in product development and business leadership across multiple industries, including medical devices and automotive.

Known information

John Gillespie currently serves as the President and CEO, having joined the company in July 2015 as Vice-President of Product and Business Development. Before his current role, he led worldwide Research and Development for three Johnson & Johnson businesses, including the multibillion-dollar Ethicon Products. Gillespie founded Clover Medical, a consulting firm, and is also a principal at startup Origami Surgical. His career includes a tenure as General Manager, North America for a subsidiary of automotive supplier Valeo, and leadership positions in product development at Baxter Healthcare. He holds an MBA in General Management from Northwestern University’s Kellogg Graduate School of Management and both a BS in Biomedical Engineering and an MS in Electrical Engineering from Boston University. Gillespie has served on the Industrial Advisory Board for the Boston University Department of Biomedical Engineering. His contributions to the field have been recognized with three Canon Publications Medical Design Excellence Awards (MDEA), and he is a co-inventor on 24 US patents.

About AmberGen

AmberGen specializes in advanced spatial biology research products, offering a range of Miralys technology-based probes, panels, and kits that enhance mass spectrometry imaging capabilities.

report flag Report inaccurate information

People similar to John Gillespie

Dr. Mark Lim

Executive Vice President and CSO @ AmberGen

Dr. Mark Lim, Executive Vice President and CSO, is a prominent figure in the biotechnology industry with over 20 years of experience, known for his significant contributions to proteomics and autoimmune disease research.

Dr. Kenneth Rothschild

Founder, Executive Chairman, and Chief Innovation Officer @ AmberGen

Dr. Kenneth Rothschild is a distinguished biotechnologist and innovator with over 35 years of contributions in various scientific fields, holding 56 U.S. patents and authoring over 150 publications.

Terry Lo

President and CEO @ Vizgen

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free